Literature DB >> 23682578

Specific miRNA expression profiles of non-tumor liver tissue predict a risk for recurrence of hepatocellular carcinoma.

Tohru Utsunomiya1, Daichi Ishikawa, Michihito Asanoma, Shinichiro Yamada, Shuichi Iwahashi, Mami Kanamoto, Yusuke Arakawa, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Hiroki Ishibashi, Chie Takasu, Mitsuo Shimada.   

Abstract

AIM: It is reasonable to investigate non-tumor liver tissues to predict a risk for development of hepatocellular carcinoma (HCC). A molecular analysis of chronically damaged liver tissues may identify specific miRNA expression profiles associated with a risk for multicentric (MC) HCC.
METHODS: Twenty HCC patients, who underwent a curative hepatectomy were classified into two groups: a non-MC group (no MC recurrence in more than 3 years, n = 10) and an MC group (MC recurrence within 3 years after hepatectomy, n = 10). An miRNA microarray (955 probes) was used to compare the miRNA expression patterns of the non-cancerous liver tissues between the two groups. This study identified the differentially expressed miRNA related to MC recurrence in the liver remnant.
RESULTS: No differences were observed between the two groups in the liver function tests and pathological variables including both tumor factors and non-tumor liver tissues. The investigation selected 20 differentially expressed miRNA related to MC recurrence. Eighteen miRNA were downregulated, while two miRNA were upregulated in the MC group. A hierarchical clustering analysis identified a cluster that may be associated with risk of the MC recurrence of HCC. The MC recurrence-related miRNA included let-7d*, miR-328 and miR18a*, which potentially regulate K-ras gene expression. A significant inverse correlation between the miR-18a* expression and the K-ras mRNA expression was confirmed by quantitative reverse transcription polymerase chain reaction.
CONCLUSION: Specific miRNA expression signatures in non-cancerous liver tissue may help to predict the risk for de novo development of HCC.
© 2013 The Japan Society of Hepatology.

Entities:  

Keywords:  hepatocellular carcinoma; miRNA microarray; multicentric occurrence; non-tumor tissue; recurrence

Year:  2013        PMID: 23682578     DOI: 10.1111/hepr.12164

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  15 in total

1.  MiRNA-145 Regulates the Development of Congenital Heart Disease Through Targeting FXN.

Authors:  Lei Wang; Danqiu Tian; Jihua Hu; Haijian Xing; Min Sun; Juanli Wang; Qiang Jian; Hua Yang
Journal:  Pediatr Cardiol       Date:  2015-12-30       Impact factor: 1.655

2.  Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors.

Authors:  Yoshikuni Inokawa; Kenichi Inaoka; Fuminori Sonohara; Masamichi Hayashi; Mitsuro Kanda; Shuji Nomoto
Journal:  Oncol Lett       Date:  2016-09-15       Impact factor: 2.967

3.  Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).

Authors:  Xiaomin Shi; Fei Teng
Journal:  Mol Cell Biochem       Date:  2015-07-10       Impact factor: 3.396

4.  Chronic inflammation with Helicobacter pylori infection is implicated in CD44 overexpression through miR-328 suppression in the gastric mucosa.

Authors:  Takatsugu Ishimoto; Daisuke Izumi; Masayuki Watanabe; Naoya Yoshida; Kosei Hidaka; Keisuke Miyake; Hidetaka Sugihara; Hiroshi Sawayama; Yu Imamura; Masaaki Iwatsuki; Shiro Iwagami; Yoshifumi Baba; Hasita Horlad; Yoshihiro Komohara; Motohiro Takeya; Hideo Baba
Journal:  J Gastroenterol       Date:  2014-12-06       Impact factor: 7.527

Review 5.  Specific molecular signatures of non-tumor liver tissue may predict a risk of hepatocarcinogenesis.

Authors:  Tohru Utsunomiya; Mitsuo Shimada; Yuji Morine; Atsushi Tajima; Issei Imoto
Journal:  Cancer Sci       Date:  2014-06-18       Impact factor: 6.716

Review 6.  The mystery of let-7d - a small RNA with great power.

Authors:  Tomasz Kolenda; Weronika Przybyła; Anna Teresiak; Andrzej Mackiewicz; Katarzyna M Lamperska
Journal:  Contemp Oncol (Pozn)       Date:  2014-11-05

7.  Identification of recurrence-related serum microRNAs in hepatocellular carcinoma following hepatectomy.

Authors:  Liming Wang; Mei Liu; Hongxia Zhu; Weiqi Rong; Fan Wu; Songlin An; Faqiang Liu; Li Feng; Jianxiong Wu; Ningzhi Xu
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

Review 8.  Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.

Authors:  A Kornberg
Journal:  ISRN Hepatol       Date:  2014-03-04

9.  After Myocardial Ischemia-Reperfusion, miR-29a, and Let7 Could Affect Apoptosis through Regulating IGF-1.

Authors:  Lei Wang; Xuehong Niu; Jihua Hu; Haijian Xing; Min Sun; Juanli Wang; Qiang Jian; Hua Yang
Journal:  Biomed Res Int       Date:  2015-12-30       Impact factor: 3.411

10.  MicroRNA-328 enhances cellular motility through posttranscriptional regulation of PTPRJ in human hepatocellular carcinoma.

Authors:  Xiaoling Luo; Shiyan Yang; Chuanwen Zhou; Feng Pan; Qianjun Li; Shijie Ma
Journal:  Onco Targets Ther       Date:  2015-10-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.